A randomized, double-blind, placebo-controlled study of the effect of ezetimibe on glucose metabolism in subjects with type 2 diabetes mellitus and hypercholesterolemia

被引：0
|
作者：
Itori Saito
Kyoichi Azuma
Taro Kakikawa
Nobuyuki Oshima
Mary E Hanson
Andrew M Tershakovec
机构：
[1] Clinical research,MSD KK, Japan development
[2] Merck & Co.,undefined
[3] Inc,undefined
来源：
Lipids in Health and Disease | / 14卷
关键词：
Fasting plasma glucose; Glycoalbumin; HbA1c; Japanese; LDL-C;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Effect of Dapagliflozin as an Add-on Therapy to Insulin on the Glycemic Variability in Subjects with Type 2 Diabetes Mellitus (DIVE): A Multicenter, Placebo-Controlled, Double-Blind, Randomized Study
    Lee, Seung-Hwan
    Min, Kyung-Wan
    Lee, Byung-Wan
    Jeong, In-Kyung
    Yoo, Soon-Jib
    Kwon, Hyuk-Sang
    Choi, Yoon-Hee
    Yoon, Kun-Ho
    DIABETES & METABOLISM JOURNAL, 2021, 45 (03) : 339 - 348
  • [22] Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: A preliminary randomized double-blind, placebo-controlled study
    Shimozato, Akihiro
    Sasaki, Makoto
    Ogasawara, Naotaka
    Funaki, Yasushi
    Ebi, Masahide
    Goto, Chiho
    Koikeda, Satoshi
    Joh, Takashi
    Kasugai, Kunio
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2017, 5 (06) : 898 - 907
  • [23] Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study
    Sasaki, Makoto
    Ogasawara, Naotaka
    Funaki, Yasushi
    Mizuno, Mari
    Iida, Akihito
    Goto, Chiho
    Koikeda, Satoshi
    Kasugai, Kunio
    Joh, Takashi
    BMC GASTROENTEROLOGY, 2013, 13
  • [24] Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study
    Makoto Sasaki
    Naotaka Ogasawara
    Yasushi Funaki
    Mari Mizuno
    Akihito Iida
    Chiho Goto
    Satoshi Koikeda
    Kunio Kasugai
    Takashi Joh
    BMC Gastroenterology, 13
  • [25] An Exploratory Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Cotadutide on Energy Balance in Overweight and Obese Subjects with Type 2 Diabetes Mellitus
    Golubic, Rajna
    Kennet, Jane
    Parker, Victoria E.
    Robertson, Darren
    Luo, Dan
    Hansen, Lars
    Jermutus, Lutz
    Ambery, Philip
    Park, Adrian
    Evans, Mark
    DIABETES, 2021, 70
  • [26] Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: A randomized, double-blind, placebo-controlled trial
    Goldberg, AC
    Sapre, A
    Liu, J
    Capece, R
    Mitchel, YB
    MAYO CLINIC PROCEEDINGS, 2004, 79 (05) : 620 - 629
  • [27] A randomized, double-blind, placebo-controlled study of the efficacy and tolerability of policosanol in adolescents with type II hypercholesterolemia
    Castaño, G
    Más, R
    Fernández, L
    Illnait, J
    Hernández, E
    Fernández, JC
    Gámez, R
    Gutiérrez, C
    Alvarez, E
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2002, 63 (04): : 286 - 303
  • [28] Repaglinide in type 2 diabetes: A randomized, double-blind, placebo-controlled, dose-response study
    Schwartz, SL
    Goldberg, RB
    Strange, P
    DIABETES, 1998, 47 : A98 - A98
  • [29] Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled trial
    Germing, A
    MEDIZINISCHE KLINIK, 2005, 100 (04) : 232 - 232
  • [30] Effect of pramlintide on ad-libitum food intake in obese subjects and subjects with Type 2 diabetes: a randomized, double-blind, placebo-controlled, crossover study
    Chapman, I
    Parker, B
    Doran, S
    Feinle-Bisset, C
    Wishart, J
    Wang, Y
    Lush, C
    Mcintyre, S
    Burrell, T
    Deckhut, D
    Weyer, C
    Horowitz, M
    DIABETOLOGIA, 2004, 47 : A283 - A284
12345